Differentially expressed genes from the glioblastoma cell line SHG-44 treated with all-trans retinoic acid in vitro

Morphology, immunocytochemistry, growth curve assay, and flow cytometry were used to investigate the effects of all-trans retinoic acid (RA) on cell proliferation, cell cycle progression and differentiation of the astrocytoma cell line SHG-44 from glioblastoma multiforme (World Health Organization grade IV). The differentially expressed genes from RA-treated and normal SHG-44 were identified by cDNA microarray after the cell line SHG-44 was treated with 10muM RA for 3 days. Validation of some differentially expressed genes was performed by Northern Blot analysis. The expression of glial fibrillary acidic protein (GFAP) was markedly increased in RA-treated SHG-44 cells. Other changes included a short shuttle shape, small nucleus, decreased karyoplasm proportion, the formation of increased thin cytoplasmic processes, reduced cell growth and a 15% increase in G0/G1 phase cell populations. In addition, 42 known genes were identified with altered expression in our cDNA microarray. There was stable down-regulation of MDM2 and UGB as well as overexpression of SOD2, CSTB, and G3BP when RA-treated SHG-44 was compared with normal SHG-44. RA simultaneously suppressed the proliferation of SHG-44 cells significantly as well as induced differentiation and altered gene expression.

[1]  Mihee M. Kim,et al.  Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP) , 2007, Oncogene.

[2]  D. Hume,et al.  Rasputin, more promiscuous than ever: a review of G3BP. , 2004, The International journal of developmental biology.

[3]  D. Keppler.  Towards novel anti-cancer strategies based on cystatin function. , 2006, Cancer letters.

[4]  S. Berg,et al.  MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death , 2006, Molecular Cancer Therapeutics.

[5]  M. Grummer,et al.  Effect of retinoic acid and ethanol on retinoic acid receptor β and glial fibrillary acidic protein mRNA expression in human astrocytoma cells , 2000, Neuroscience Letters.

[6]  Tews Ds.  Cell death and oxidative stress in gliomas. , 1999 .

[7]  J. Rommelaere,et al.  Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells , 2007, Journal of Virology.

[8]  E. Kim,et al.  Inhibition of Caco‐2 cell proliferation by all‐trans retinoic acid: Role of insulin‐like growth factor binding protein‐6 , 2002, Journal of cellular physiology.

[9]  D. Brat,et al.  Differential Expression between Pilocytic and Anaplastic Astrocytomas: Identification of Apolipoprotein D as a Marker for Low‐Grade, Non‐Infiltrating Primary CNS Neoplasms , 2002, Journal of neuropathology and experimental neurology.

[10]  B. Wasylyk,et al.  MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice , 1999, Oncogene.

[11]  G. Lozano,et al.  Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4 , 2006, Molecular and Cellular Biology.

[12]  Webster K. Cavenee,et al.  The WHO Classification of Tumors of the Nervous System , 2002 .

[13]  Y. Liu,et al.  Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic. , 2001, Chinese Medical Journal.

[14]  K. Vousden,et al.  Activation and activities of the p53 tumour suppressor protein , 2001, British Journal of Cancer.

[15]  K. Chébli,et al.  The RasGAP-associated endoribonuclease G3BP assembles stress granules , 2003, The Journal of cell biology.

[16]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[17]  L. Oberley,et al.  The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. , 2003, Cancer research.

[18]  M. Watson,et al.  Mammaglobin, a Breast‐Specific Gene, and Its Utility as a Marker for Breast Cancer , 2000, Annals of the New York Academy of Sciences.

[19]  W. Farrar,et al.  Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. , 2005, Cancer research.

[20]  Jae Cheol Lee,et al.  Inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell lines , 2003, Cancer Gene Therapy.

[21]  P. Thibault,et al.  Identification of differentially expressed proteins in human glioblastoma cell lines and tumors , 2003, Glia.

[22]  P. Black,et al.  Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines. , 2000, Neurosurgery.

[23]  C. J. Barnes,et al.  Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. , 2002, Cancer research.

[24]  P. Hutzler,et al.  HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes , 2011, Journal of NeuroVirology.

[25]  E. Baldi,et al.  Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC‐1A by disrupting the metabolic pathways generating platelet‐activating factor , 2000, International journal of cancer.

[26]  E. Hurt,et al.  Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines , 2007, British Journal of Cancer.

[27]  E. May,et al.  Reciprocal down-regulation of p53 and SOD2 gene expression–implication in p53 mediated apoptosis , 2001, Oncogene.

[28]  Hsiao-Huei Wu,et al.  MDM2--master regulator of the p53 tumor suppressor protein. , 2000, Gene.

[29]  Hui Wang,et al.  Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. , 2005, Cancer research.